Course Overview
|
Course Synopsis
|
This course is designed to develop understanding of the students about the scope of biotechnology, Differentiate between the fine differences between biotechnology and allied fields, Appreciate the commercial potential of biotechnology products, understand the principles of microbial growth and relate them with large scale manufacturing at the industrial scale,
Appreciate advances in healthcare biotechnology and understand how it is shaping up modern biopharmaceutical sector, Comprehend how biotechnology is protecting the environment, understand how analytical biotechnology is exploited to make biosensors, how biotechnology products are going to revolutionize clinical trials, what are going to be fuels of the future
|
Course Learning Outcomes
|
After completing this course, students will be able to
- Understand and comprehend the scope of biotechnology
- Differentiate between the fine differences between biotechnology and allied fields
- Appreciate the commercial potential of biotechnology products
- Understand the principles of microbial growth and relate them with large scale manufacturing at the industrial scale
- Identify and differentiate between various fermentation systems
- Appreciate advances in healthcare biotechnology and understand how it is shaping up modern biopharmaceutical sector
- Understand how analytical biotechnology is exploited to make biosensors
- know about biotechnology products that are going to revolutionize clinical trials
|
Course Calendar
|
|
2
|
Biotechnology in 21st Century
|
|
4
|
Roots of Biotechnology_2
|
|
7
|
Commercialising Biotechnology
|
|
11
|
Human Genome Project_2
|
|
24
|
Expanding the genetic code
|
|
27
|
Foreces Defining Protein Structure
|
|
28
|
Forces Defining Protein Structure_2
|
|
32
|
Super Secornday and Tertiary
|
|
33
|
Super Secondary & Tertiary_2
|
|
34
|
Engineering the three domains
|
|
35
|
Engineering the three domains_2
|
|
36
|
Learning from extremophiles
|
|
37
|
Learning from extremophiles_2
|
|
38
|
Engineering the Prokaryotes
|
|
39
|
Restriction Endonuclease_1
|
|
40
|
Restriction Endonuclease_2
|
|
43
|
Plasmid Classification
|
|
45
|
Development of Plasmids
|
|
46
|
Insertional Inactivation
|
|
48
|
Life cycle of Bacteriophage
|
|
49
|
Vectors based on the lambda _1
|
|
50
|
Vectors based on the lambda _2
|
|
54
|
Making genomic libraries in E.coli
|
|
56
|
Bacterial Growth Curve
|
|
57
|
Measuring Bacterial Growth
|
|
58
|
High Copy number & Expression Strategies_1
|
|
59
|
High Copy number & Expression Strategies_2
|
|
60
|
Protein Secretion Pathway
|
|
61
|
Type 1 Protein Secretory Pathway
|
|
62
|
Type 2 Protein Secretory Pathway
|
|
63
|
Type 3 Protein Secretory Pathway
|
|
64
|
Type 3 Protein Secretory Pathway_2
|
|
65
|
Type 4 Protein Secretory Pathway
|
|
66
|
Type 5& 6 Protein Secretory Pathway
|
|
67
|
Gram Positive Bacteria
|
|
68
|
Secretions & Biotechnology
|
|
69
|
Benefits to clone in Eukaryotes
|
|
70
|
Post translational modification of Proteins
|
|
71
|
Post translational modification of Proteins_2
|
|
72
|
Types of Eukaryotic Expression System
|
|
73
|
Saccharomyces cerevisae
|
|
74
|
Transofrmation in Yeast
|
|
82
|
Baculovirus-Insect Expression System
|
|
83
|
Baculovirus-Insect Expression System_2
|
|
86
|
Mammalian Cell Expression
|
|
87
|
Vectors for Mammalian Cell Expression
|
|
88
|
Vectors for Mammalian Cell Expression_2
|
|
89
|
Enhancing the Productivity
|
|
90
|
Enhancing the Productivity_2
|
|
91
|
Genome Editing Technologies
|
|
94
|
Pharmaceutical Biotechnology
|
|
95
|
Pharmaceutical Biotechnology Market
|
|
97
|
Receptors and Drugable Proteins
|
|
103
|
Drawbacks of Animal Insulin
|
|
104
|
Genetically Engineered Insulin Production
|
|
105
|
Genetically Engineered Insulin Production_2
|
|
110
|
Human growth hormone the molecule
|
|
111
|
Therapeutic uses of growth harmone
|
|
113
|
Male Reproductive System
|
|
114
|
Female Reproductive System
|
|
115
|
Female Reproductive System-2
|
|
116
|
Follicle Stimulating Hormone
|
|
117
|
Applications of Gonadotrophins
|
|
118
|
Vaccines a historical perspective 1
|
|
119
|
Vaccines a historical perspective 2
|
|
120
|
Traditional Vaccine preparation 1
|
|
121
|
Traditional Vaccine preparation 2
|
|
122
|
Recombinant vaccines_1
|
|
123
|
Recombinant vaccines_2
|
|
124
|
Recombinant vaccines_3
|
|
128
|
Drug Development Process
|
|
129
|
Point of care diagnostics
|
|
130
|
Point of care diagnostics 2
|
|
131
|
Point of care diagnostics 3
|
|
132
|
Theranostics & Pay for performance
|
|
134
|
Lateral Flow Immunoassay
|
|
|
|